Advancing the development of an effective COVID-19 vaccine
We will soon be recruiting more participants for the next phase of our COVID-19 vaccine trial at our West London study facility.
Following extensive pre-clinical testing, this next phase of the trial will allow us to refine our innovative, self-amplifying RNA vaccine for the first time in humans.
If you are interested in taking part, please see further details on how to participate and complete our pre-screening questionnaire. You can also find more information about the trial and its structure, as well as the science behind the vaccine, on this site.
This trial is supported by generous funding from the UK government, UK Research and Innovation (UKRI), the Medical Research Council (MRC), the National Institute for Health Research (NIHR), Partners of Citadel and Citadel Securities, Sir Joseph Hotung Charitable Settlement, Jon Moulton Charity Trust, Pierre Andurand and Restore Our Planet.
Find out more about our response to the coronavirus pandemic.
17 February 2021COVID-19 vaccine Q&A - latest news, antibody tests and tackling new…
25 November 2020Podcast: Statin side effects, vaccine latest and pandemic politics
BBC News: revolutionary COVID-19 vaccine trial begins
Fergus Walsh reports on the launch of Imperial's coronavirus vaccine trial
The BBC's Fergus Walsh reports as hundreds of volunteers are to take part in the trial of a new vaccine against coronavirus over the coming weeks, as part of a project led by scientists at Imperial College London.
AHSC seminar: Developing a vaccine for COVID-19
Professor Robin Shattock talks about his work leading a team developing a coronavirus vaccine
Professor Robin Shattock talks about his work leading a team developing a coronavirus vaccine, as part of the Imperial College Academic Health Science Centre COVID-19 online seminar series.
Dr Hannah Cheeseman explains Imperial's vaccine trial
Dr Hannah Cheeseman breaks down some of the key questions on Imperial's COVID-19 vaccine study
Dr Hannah Cheeseman breaks down some of the key questions surrounding Imperial's COVID-19 vaccine study, which launched in June 2020.
Dr Anna Blakney discusses RNA vaccines
RNA vaccines are the same type being trialled for COVID-19
Dr Anna Blakney, Research Fellow in Professor Robin Shattock's lab, discusses RNA vaccines, the same type being trialled for COVID-19.